Literature DB >> 16673052

Prophylactic antibiotics after urodynamics in women: a decision analysis.

Jerry L Lowder1, Lara J Burrows, Nancy L S Howden, Anne M Weber.   

Abstract

The objective of this paper is to compare the risks and benefits of antibiotics to prevent urinary tract infection (UTI) after urodynamics. We developed a decision analytic model to compare the use of prophylactic antibiotics with no antibiotic use after urodynamics to prevent UTI. Risks and benefits were estimated from the literature and by consensus. The main outcome measure was the occurrence of UTI. Secondary outcomes were the development of adverse events and possible sequelae. One-way sensitivity analyses estimated the effect of varying each characteristic through its range while all other characteristics were fixed at their baseline values. The effectiveness of prophylaxis after urodynamics was a reduction of UTI from 9.2 (no antibiotics) to 5.3% (antibiotics). One-way sensitivity analysis of the probability of UTI without prophylaxis yielded a threshold infection rate of 10%, below which, the strategy of no prophylaxis was favored. In this model, prophylactic antibiotics after urodynamics are not beneficial until the rate of UTI without antibiotics exceeds 10%.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16673052     DOI: 10.1007/s00192-006-0121-y

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  12 in total

1.  Is antibiotic prophylaxis necessary for routine urodynamic investigations? A controlled study in 100 patients.

Authors:  M J Coptcoat; C Reed; J Cumming; P J Shah; P H Worth
Journal:  Br J Urol       Date:  1988-04

2.  Urinary tract infection after urodynamic studies in women: incidence and natural history.

Authors:  L Bombieri; D A Dance; G W Rienhardt; A Waterfield; R M Freeman
Journal:  BJU Int       Date:  1999-03       Impact factor: 5.588

3.  Antibiotic prophylaxis after instrumentation for urodynamic testing.

Authors:  A Bergman; T A McCarthy
Journal:  Br J Urol       Date:  1983-10

4.  Antibiotic treatment to prevent urinary tract infections after urodynamic evaluation.

Authors:  U M Peschers; V Kempf; K Jundt; I Autenrieth; T Dimpfl
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2001

5.  Morbidity of the evaluation of the lower urinary tract with transurethral multichannel pressure-flow studies.

Authors:  H C Klingler; S Madersbacher; B Djavan; G Schatzl; M Marberger; C P Schmidbauer
Journal:  J Urol       Date:  1998-01       Impact factor: 7.450

6.  Evaluation of morbidity of multi-channel pressure-flow studies.

Authors:  D Porru; G Madeddu; G Campus; I Montisci; R M Scarpa; E Usai
Journal:  Neurourol Urodyn       Date:  1999       Impact factor: 2.696

7.  Urinary tract infection after cystometry.

Authors:  K Sabanathan; H M Duffin; C M Castleden
Journal:  Age Ageing       Date:  1985-09       Impact factor: 10.668

8.  Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates.

Authors:  William J Burman; Peter E Breese; Barbara E Murray; Kavindra V Singh; Holly A Batal; Thomas D MacKenzie; John W Ogle; Michael L Wilson; Randall R Reves; Philip S Mehler
Journal:  Am J Med       Date:  2003-10-01       Impact factor: 4.965

9.  Effectiveness of antibiotic prophylaxis in preventing bacteriuria after multichannel urodynamic investigations: a blind, randomized study in 124 female patients.

Authors:  K R Baker; H P Drutz; M D Barnes
Journal:  Am J Obstet Gynecol       Date:  1991-09       Impact factor: 8.661

10.  An age-related investigation of urinary tract symptoms and infection following urodynamic studies.

Authors:  D Harari; J Malone-Lee; G L Ridgway
Journal:  Age Ageing       Date:  1994-01       Impact factor: 10.668

View more
  12 in total

1.  Occult incontinence in women with pelvic organ prolapse - Does it matter?

Authors:  K Jundt; S Wagner; V von Bodungen; K Friese; U M Peschers
Journal:  Eur J Med Res       Date:  2010-03-30       Impact factor: 2.175

2.  Prophylactic antibiotics to prevent urinary tract infection during clean intermittent self-catheterization (CISC) for management of voiding dysfunction after prolapse and incontinence surgery: a decision analysis.

Authors:  Gary Sutkin; Jerry L Lowder; Kenneth J Smith
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-04-10

Review 3.  Double-blinded randomized trial of preoperative antibiotics in midurethral sling procedures and review of the literature.

Authors:  Oz Harmanli; Rebecca L Boyer; Stephen Metz; Elena Tunitsky; Keisha A Jones
Journal:  Int Urogynecol J       Date:  2011-07-26       Impact factor: 2.894

4.  The effect of abdominal and pelvic floor muscle activation patterns on urethral pressure.

Authors:  Ruth R Sapsford; Barton Clarke; Paul W Hodges
Journal:  World J Urol       Date:  2012-11-29       Impact factor: 4.226

5.  Antibiotic prophylaxis in gynaecologic procedures.

Authors:  Nancy Van Eyk; Julie van Schalkwyk
Journal:  J Obstet Gynaecol Can       Date:  2012-04

6.  Bacteriuria and safety of female urodynamic studies.

Authors:  Anil Krishna Dass; Tsia-Shu Lo; Siwatchaya Khanuengkitkong; Yiap-Loong Tan
Journal:  Int Urogynecol J       Date:  2012-09-28       Impact factor: 2.894

7.  Clinical relevance of occult stress urinary incontinence (OSUI) following vaginal prolapse surgery: long-term follow-up.

Authors:  Stefanie Ennemoser; Mirjam Schönfeld; Vera von Bodungen; Darius Dian; Klaus Friese; Katharina Jundt
Journal:  Int Urogynecol J       Date:  2012-05-12       Impact factor: 2.894

8.  Prophylactic Antibiotics for Urinary Tract Infections after Urodynamic Studies: A Meta-Analysis.

Authors:  Xiao-Yu Wu; Yu Cheng; Sheng-Fei Xu; Qing Ling; Xiao-Yi Yuan; Guang-Hui Du
Journal:  Biomed Res Int       Date:  2021-02-28       Impact factor: 3.411

9.  Prophylactic antibiotic use in pediatric patients undergoing urinary tract catheterization: a survey of members of the Society for Pediatric Urology.

Authors:  Alexander P Glaser; Ilina Rosoklija; Emilie K Johnson; Elizabeth B Yerkes
Journal:  BMC Urol       Date:  2017-09-06       Impact factor: 2.264

10.  Should We Always Use Antibiotics after Urodynamic Studies in High-Risk Patients?

Authors:  Pawel Miotla; Sara Wawrysiuk; Kurt Naber; Ewa Markut-Miotla; Pawel Skorupski; Katarzyna Skorupska; Tomasz Rechberger
Journal:  Biomed Res Int       Date:  2018-11-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.